Catalog No.
EVV31401
Expression system
Mammalian Cells
Species
Zika virus (ZIKV)
Protein length
Ile291-Ser741
Predicted molecular weight
51.85 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q32ZE1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Capsid protein C, Capsid protein, Core protein, Protein prM, Precursor membrane protein, Peptide pr, Peptide precursor, Small envelope protein M, Matrix protein, Envelope protein E, Non-structural protein 1, NS1, Non-structural protein 2A, NS2A, Serine protease subunit NS2B, Flavivirin protease NS2B regulatory subunit, Non-structural protein 2B, Serine protease NS3, 3.4.21.91, 3.6.1.15, 3.6.4.13, Flavivirin protease NS3 catalytic subunit, Non-structural protein 3, Non-structural protein 4A, NS4A, Peptide 2k, Non-structural protein 4B, NS4B, RNA-directed RNA polymerase NS5, 2.1.1.56, 2.1.1.57, 2.7.7.48, NS5
Structural basis for antibody cross-neutralization of dengue and Zika viruses., PMID:40502094
Purification, refolding, and pH-dependent stability evaluation of Zika virus EDIII protein., PMID:40478414
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity., PMID:40432061
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico., PMID:40431603
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage., PMID:40425591
Autophagy-mediated downregulation of AXL and TIM-1 promotes sustained Zika virus infection., PMID:40408405
Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258
A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses., PMID:40364846
Heterologous prime-boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models., PMID:40352923
Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease., PMID:40333188
Targeting immunogenic proteins of Zika virus for the prediction of immunoinformatics-driven circular mRNA vaccine model., PMID:40291442
Multi-omics analysis reveals key immunogenic signatures induced by oncolytic Zika virus infection of paediatric brain tumour cells., PMID:40240536
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity., PMID:40202994
Anellovirus abundance as an indicator for viral metagenomic classifier utility in plasma samples., PMID:40148934
Genome-Wide Analysis of Stable RNA Secondary Structures across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics., PMID:40131856
Altered Cellular Pathways in the Blood of Patients With Guillain-Barre Syndrome., PMID:40099626
Identification of B-cell epitopes of Indian Zika virus strains using immunoinformatics., PMID:40083545
Caspase-1/11 controls Zika virus replication in astrocytes by inhibiting glycolytic metabolism., PMID:40070207
High correlation between detection of dengue IgG from dried blood spots and serum using an indirect IgG ELISA assay: A validation study in Fortaleza, Brazil., PMID:40019871
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865
Virus-like particle vaccine with authentic quaternary epitopes protects against Zika virus-induced viremia and testicular damage., PMID:40013767
Critical parameters on Zika virus-like particles' generation., PMID:39978420
Dual roles of exostosin glycosyltransferase 1 in Zika virus infection., PMID:39927690
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches., PMID:39905499
Dual surrogate imprinting: an innovative strategy for the preparation of virus-selective particles., PMID:39846824
A Lambda-evo (λevo) phage platform for Zika virus EDIII protein display., PMID:39820667
Autophagy-Mediated Downregulation of AXL and TIM-1 Promotes Sustained Zika Virus Infection., PMID:39803534
Serologic and Molecular Evidence of Arboviruses in Nonhuman Primates in Northeast Brazil., PMID:39799547
Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2., PMID:39796052
Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis., PMID:39789283
Ubiquitin-like modifier-activating enzyme 1 interacts with Zika virus NS5 and promotes viral replication in the infected cell., PMID:39773572
Cardiac Biomarkers in a Brazilian Indigenous Population Exposed to Arboviruses: A Cross-Sectional Study., PMID:39772209
A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses., PMID:39764453
ITGB4/CD104 mediates zika virus attachment and infection., PMID:39737945
Identification and Evaluation of Natural Compounds as Potential Inhibitors of NS2B-NS3 Zika Virus Protease: A Computational Approach., PMID:39733219
Designing of new trans-stilbene derivative: An entry barrier of Zika virus in host cell., PMID:39731815
High glucose potentiates Zika virus induced-astroglial dysfunctions., PMID:39625558
Serotype-Specific Dengue Virus IgG Assay Using EDIII-Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil., PMID:39620308
Analysis of the heterologous expression, localization, and cellular response to the Zika virus E protein in vitro., PMID:39605121
Analysis of Memory Antibody Responses in Individuals with Zika-Associated Guillain-Barré Syndrome., PMID:39599819
An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice., PMID:39588106
Immunogenicity and protection of a triple repeat domain III mRNA vaccine against Zika virus., PMID:39547049
Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques., PMID:39545728
Membrane fusion by dengue virus: The first step., PMID:39522596
Preparation and Construction of Chimeric Humanized Broadly Reactive Antibody 10H10 to Protein E of Tick-Borne Encephalitis Virus., PMID:39441444
Envelope Protein in Differential Serodiagnosis of Dengue, Zika and Chikungunya Viruses: A Systematic Review., PMID:39428933
Genome-Wide Identification of Stable RNA Secondary Structures Across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics., PMID:39416040
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice., PMID:39414822
For research use only. Not for human or drug use.
